Which preventive checks do people with a chronic condition actually miss
Longetic holds the dates, so the question "when was my last kidney check" has an answer instead of a shrug. The checks people with a chronic condition miss are mostly the ones their own diagnosis adds: an annual urine albumin-to-creatinine ratio, a dilated eye exam, a foot exam, and two or three extra vaccinations. General cancer screening slips too, but by less than most articles imply.
There is a story that gets repeated in health writing: people who are busy managing a chronic illness fall through the cracks on everything else. It is half true, and the half that is false matters, because it sends you looking in the wrong place.
The evidence on general preventive care points the other way. In a study of 667,379 primary-care patients, of whom 65.4% had at least one chronic illness, having a chronic illness was positively associated with 9 of the 10 preventive services measured, and the odds rose as the number of conditions rose. The authors put it plainly: "Rather than a barrier, the presence of chronic illness was positively associated with receipt of recommended preventive services." More visits means more chances to be offered something.
The gap is narrower and more specific than "everything". It sits in three places: cancer screening for some groups, condition-specific monitoring, and adult vaccination.
Does a chronic condition mean you get less cancer screening
Longetic cannot book a mammogram and does not decide who needs one, but the result, the note from the breast clinic visit and whatever was agreed there as the next step all sit in one searchable history. The published evidence shows a real but modest dip for people with diabetes, and no clear effect for multimorbidity on its own. The strongest predictor of a missed screening in the largest datasets is insurance and income.
A meta-analysis of 37 studies found that people with diabetes had lower uptake of breast screening (odds ratio 0.83, 95% CI 0.77 to 0.90) and cervical screening (OR 0.76, 95% CI 0.71 to 0.81), with no significant overall difference for colorectal screening (OR 0.95, 95% CI 0.86 to 1.06). The authors called the absolute differences "modest".
Stacking matters more than any single diagnosis. Among 3,306 Appalachian Medicare beneficiaries, women with three or four chronic diseases had 33% lower odds of a screening mammogram (OR 0.669) and women with five or more had 41% lower odds (OR 0.597), while a single chronic disease showed no independent association at all (OR 0.976).
| What the data shows | Effect size | Source |
|---|---|---|
| Chronic illness and 9 of 10 preventive services | positive association | Ornstein 2013, 667,379 patients |
| Diabetes and breast screening | OR 0.83 | Zhu 2020 meta-analysis |
| Diabetes and cervical screening | OR 0.76 | Zhu 2020 meta-analysis |
| Three to four conditions and mammography | OR 0.669 | Medicare cohort 2020 |
| Five or more conditions and mammography | OR 0.597 | Medicare cohort 2020 |
| Multimorbidity and later breast, colorectal or prostate cancer | no significant association | UK Biobank, 436,990 adults |
One more finding complicates the "doctors forget" narrative. Among 20,080 women aged 21 to 65, those with diabetes or hypertension were more likely to have been told to get a cervical screening test (64% against 60%) and less likely to be up to date on it (79% against 84%). Being told and getting it done are two different numbers.
What does your own condition add to the schedule
Longetic keeps the last value and the date of each of these in one place, which is the part people lose track of. A chronic diagnosis comes with its own monitoring calendar, and it runs on shorter intervals than the general adult schedule. For type 2 diabetes the ADA Standards of Care in Diabetes 2026 asks for kidney function at least once a year, and more often once kidney disease is established.
The exact wording of Recommendation 11.1a is worth reading, because it applies to everyone with type 2 diabetes and not only to people who already have a kidney problem: "Assess kidney function (i.e., spot urine albumin-to-creatinine ratio [UACR]) and estimated glomerular filtration rate [eGFR] in people with type 1 diabetes with duration of ≥5 years and in all people with type 2 diabetes regardless of treatment." Recommendation 11.1b then raises the frequency: "In people with established chronic kidney disease (CKD), monitor urinary albumin (e.g., spot UACR) and eGFR 1–4 times per year depending on the stage of the kidney disease."
| Condition | What the guideline asks for | How often | Source |
|---|---|---|---|
| Type 2 diabetes | uACR and eGFR | at least yearly | ADA 2026, Rec 11.1a |
| Type 2 diabetes | dilated eye exam | at diagnosis, then every 1 to 2 years if no retinopathy | ADA Standards of Care |
| Type 2 diabetes | foot and neuropathy assessment | yearly, every visit if sensory loss | ADA Standards of Care |
| Type 2 diabetes | dental exam | at least yearly | ADA Standards of Care |
| Chronic kidney disease | albuminuria and GFR | at least yearly, more if progressing | KDIGO 2024, Practice Point 2.1.1 |
| CKD stage G4 with severe albuminuria | albuminuria and GFR | 3 times a year | NICE NG203, Table 2 |
| CKD stage G5 | albuminuria and GFR | 4 times a year or more | NICE NG203, Table 2 |
| Diabetes, CKD stage 3 or 4, or HIV, ages 40 to 75 | LDL-lowering therapy considered | regardless of LDL-C level | 2026 ACC/AHA dyslipidaemia guideline |
The KDIGO 2024 CKD guideline states the floor in one sentence: "Assess albuminuria in adults, or albuminuria/proteinuria in children, and GFR at least annually in people with CKD." The UK equivalent, NICE NG203, publishes an actual grid of minimum frequencies by GFR and albuminuria category, from once a year up to four times a year, and calls those minimums rather than targets.
Two of these are the ones that vanish from a busy year. The urine test is easy to skip because it feels minor next to an HbA1c. The dilated eye exam happens in a different building, with a different clinician, on a different schedule, which is exactly the kind of appointment nobody remembers booking.
Which vaccinations does a chronic condition add
Longetic stores vaccination records next to lab results and visits, so the gap shows up as a missing entry rather than a memory test. A chronic condition moves several adult vaccines from "later" to "now", most notably pneumococcal, which the CDC schedule recommends from age 19 rather than 50 for adults with chronic heart, lung, liver or kidney disease, diabetes, or an immunocompromising condition.
Uptake here is the weakest link in the whole article. Among US adults with cardiovascular disease, influenza vaccination coverage rose from 38.6% in 2011 to only 44.3% in 2020, and no state reached the Healthy People 2020 target of 70%. In the same data, uninsured people with cardiovascular disease sat at 24.5% coverage against 48.2% for insured ones.
| Vaccine | Standard adult trigger | What a chronic condition changes | Source |
|---|---|---|---|
| Pneumococcal | age 50 | ages 19 to 49 qualify with chronic heart, lung, liver or kidney disease, diabetes, asplenia, HIV or malignancy | CDC adult schedule |
| Shingles | age 50, two doses | same series at any age if immunocompromised | CDC adult schedule |
| Hepatitis B | routine series, ages 19 to 59 | ages 60+ with diabetes moves to shared clinical decision-making | CDC adult schedule |
| Influenza | yearly, all adults 19+ | higher-dose or adjuvanted formulations preferred at 65+ | CDC adult schedule |
| RSV | age 75+ | ages 50 to 74 at increased risk of severe disease, one dose | CDC adult schedule |
The CDC adult immunization schedule is a US document. European schedules are set nationally, so the ages and triggers differ, and a reader in Germany or France should check STIKO or the national calendar rather than assume the US table applies.
How does follow-up differ between countries
Longetic is the copy of your record that stays yours when the system around you changes, which is the point of this section. Structured follow-up for a chronic condition is not a universal fact, it is national policy. Germany runs a quarterly programme you enrol in, England runs an annual set of care processes tracked by audit, France guarantees reimbursement rather than a schedule, and the US leaves the cadence to your insurer and your clinician.
| Country | What is organised | Cadence | What it does not guarantee |
|---|---|---|---|
| Germany | Disease-Management-Programm for type 2 diabetes, enrolled through your statutory insurer | follow-up documentation every 3 months, eye exam and microalbuminuria yearly | attendance, which is still on you |
| England | the diabetes care processes tracked by the National Diabetes Audit | "reviewed at least once a year" | completion, 44.7% of people with type 2 diabetes in the most deprived quintile got all eight in 2021-22 |
| France | Affection de Longue Durée status, 100% reimbursement for condition-related care under a protocole de soins | HbA1c at least every 3 months, eye, kidney, lipids and feet at least yearly, per patient-association guidance | an enforced visit schedule |
| United States | clinical guidelines only | as per ADA, KDIGO and ACC/AHA above | anything, coverage drives receipt |
The English number is the one to sit with. Even inside a national programme with an audit attached, fewer than half the people in the most deprived quintile completed all eight care processes in a year. A schedule existing somewhere is not the same as a schedule happening to you.
How do you know what is already done and what is due
Longetic charts each biomarker across every report you upload and keeps visits and diagnoses on the same timeline, so the last uACR has a date next to it. Answering "what is due" needs two things: the list of what your condition asks for, and the date each one last happened. Most people have the first from their clinician and lose the second across letters, portals and PDFs.
Portals solve part of this, inside one health system. Move country, change insurer or see a specialist outside the network, and the trail breaks. That is the specific gap a personal record fills: it is the copy that does not belong to a clinic.
Several tools do some version of this. Guava Health connects to US patient portals and builds summaries. KeepMD keeps records, labs, visits and medication context in one timeline and exports PDF, CSV and FHIR on its paid plan. Apple Health Records pulls data from participating institutions. Longetic reads lab reports you upload as PDF or photo from any laboratory, charts each biomarker over time, and keeps medications, diagnoses and visits in the same searchable history, with re-check reminders. As a disclosure, Longetic is our product, so weigh that mention accordingly. It is iPhone only, there is no Android app, and it does not tell you what any result means or what to do about it.
Paying for a check is a separate question again, and we cover who pays for a preventive screening in a US plan on its own page. What none of them do is decide your schedule. That belongs with the clinician who knows your history, and the useful thing you can bring to that conversation is a list of dates.
